KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Davita (DVA) Non-Current Receivables (2009 - 2016)

Davita (DVA) reported Non-Current Receivables of -$4.1 billion for Q4 2016, up 1.4% year-over-year from -$4.1 billion in Q1 2016, and down 601.82% on a QoQ basis from $820.5 million in Q3 2016.

Davita (DVA) has 8 years of Non-Current Receivables data on file, last reported at -$4.1 billion in Q4 2016.

  • Quarterly Non-Current Receivables rose 1.4% year-over-year to -$4.1 billion in Q4 2016, while the trailing twelve-month figure through Dec 2016 was -$4.1 billion (up 1.4% YoY) and the FY2016 annual result came in at -$4.1 billion, up 1.4% from the prior year.
  • Non-Current Receivables retreated to -$4.1 billion in Q4 2016 per DVA's latest filing, from $820.5 million in the prior quarter.
  • Across five years, Non-Current Receivables topped out at $3.8 billion in Q1 2014 and bottomed at -$4.8 billion in Q2 2013.
  • The 5-year median for Non-Current Receivables is $566.6 million (2012), against an average of $551.6 million.
  • The widest annual swing landed in 2013, when Non-Current Receivables sank 971.16%; it then surged 2273.93% in 2014.
  • Tracing DVA's Non-Current Receivables over 5 years: stood at $423.6 million in 2012, then gained by 13.54% to $481.0 million in 2013, then jumped by 674.12% to $3.7 billion in 2014, then slumped by 212.15% to -$4.2 billion in 2015, then rose by 1.4% to -$4.1 billion in 2016.
  • Per Business Quant, the three latest DVA Non-Current Receivables figures stand at -$4.1 billion (Q4 2016), $820.5 million (Q3 2016), and $3.5 billion (Q2 2016).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Receivables (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn -
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn -
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn -
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn -
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Option Care Health 3.27 Bn 3.09 Bn 262.01 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2016 -4.12 Bn
Sep 30, 2016 820.54 Mn
Jun 30, 2016 3.47 Bn
Mar 31, 2016 3.80 Bn
Dec 31, 2015 -4.18 Bn
Sep 30, 2015 644.47 Mn
Jun 30, 2015 -4.36 Bn
Mar 31, 2015 587.51 Mn
Dec 31, 2014 3.72 Bn
Sep 30, 2014 3.45 Bn
Jun 30, 2014 3.65 Bn
Mar 31, 2014 3.82 Bn
Dec 31, 2013 480.99 Mn
Sep 30, 2013 3.70 Bn
Jun 30, 2013 -4.75 Bn
Mar 31, 2013 160.96 Mn
Dec 31, 2012 423.63 Mn
Sep 30, 2012 -1.08 Bn
Jun 30, 2012 545.65 Mn
Mar 31, 2012 245.33 Mn
Dec 31, 2011 472.20 Mn
Sep 30, 2011 428.43 Mn
Jun 30, 2011 176.87 Mn
Mar 31, 2011 639.51 Mn
Dec 31, 2010 208.03 Mn
Sep 30, 2010 11.12 Mn
Jun 30, 2010 38.73 Mn
Dec 31, 2009 226.86 Mn